These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38104075)

  • 41. Obstetric imaging practice characteristics associated with prenatal detection of critical congenital heart disease in a rural US region over 20 years.
    McLean KC; Meyer MC; Peters SR; Wrenn LD; Yeager SB; Flyer JN
    Prenat Diagn; 2024 Jun; 44(6-7):698-705. PubMed ID: 38459708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for Critical Congenital Heart Disease in Newborns.
    Bruno CJ; Havranek T
    Adv Pediatr; 2015 Aug; 62(1):211-26. PubMed ID: 26205115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of critical congenital heart disease among newborns in Argentina through the national surveillance system of congenital heart disease (RENAC).
    Groisman B; Barbero P; Liascovich R; Brun P; Bidondo MP
    Arch Argent Pediatr; 2022 Feb; 120(1):6-13. PubMed ID: 35068114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proportion of critical congenital heart defects attributable to unhealthy prepregnancy body mass index among women with live births in Florida, 2005-2016.
    Rutkowski RE; Tanner JP; Anjohrin SB; Kirby RS; Salemi JL
    Birth Defects Res; 2021 Nov; 113(18):1285-1298. PubMed ID: 34390321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Actions in Support of Newborn Screening for Critical Congenital Heart Disease - United States, 2011-2018.
    Glidewell J; Grosse SD; Riehle-Colarusso T; Pinto N; Hudson J; Daskalov R; Gaviglio A; Darby E; Singh S; Sontag M
    MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(5):107-111. PubMed ID: 30730872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of Pulse Oximetry Screening for Critical Congenital Heart Defects after Home Birth and Early Postnatal Discharge.
    Narayen IC; Blom NA; van Geloven N; Blankman EIM; van den Broek AJM; Bruijn M; Clur SB; van den Dungen FA; Havers HM; van Laerhoven H; Mir SE; Muller MA; Polak OM; Rammeloo LAJ; Ramnath G; van der Schoor SRD; van Kaam AH; Te Pas AB;
    J Pediatr; 2018 Jun; 197():29-35.e1. PubMed ID: 29580679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on Prenatal Detection Rate of Critical Congenital Heart Disease Before and During the COVID-19 Pandemic.
    Gupta D; Vuong T; Wang S; Korst LM; Pruetz JD
    Pediatr Cardiol; 2024 Jun; 45(5):1015-1022. PubMed ID: 38565667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results from the New Jersey statewide critical congenital heart defects screening program.
    Garg LF; Van Naarden Braun K; Knapp MM; Anderson TM; Koppel RI; Hirsch D; Beres LM; Sweatlock J; Olney RS; Glidewell J; Hinton CF; Kemper AR
    Pediatrics; 2013 Aug; 132(2):e314-23. PubMed ID: 23858425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inadequacies of hospital-level critical congenital heart disease screening data reports: implications for research and quality efforts.
    Siefkes H; Kair LR; Saarinen A; Lakshminrusimha S
    J Perinatol; 2021 Jul; 41(7):1611-1620. PubMed ID: 32792631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
    Peterson C; Grosse SD; Glidewell J; Garg LF; Van Naarden Braun K; Knapp MM; Beres LM; Hinton CF; Olney RS; Cassell CH
    Public Health Rep; 2014; 129(1):86-93. PubMed ID: 24381364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
    Steurer MA; Peyvandi S; Baer RJ; Oltman SP; Chambers CD; Norton ME; Ryckman KK; Moon-Grady AJ; Keller RL; Shiboski SC; Jelliffe-Pawlowski LL
    J Am Heart Assoc; 2019 Nov; 8(22):e013194. PubMed ID: 31726960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulse oximetry as a screening test for critical congenital heart disease in term newborns.
    Gómez-Rodríguez G; Quezada-Herrera A; Amador-Licona N; Carballo-Magdaleno D; Rodríguez-Mejía EJ; Guízar-Mendoza JM
    Rev Invest Clin; 2015; 67(2):130-4. PubMed ID: 25938847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of critical congenital heart disease screening in Minnesota.
    Kochilas LK; Lohr JL; Bruhn E; Borman-Shoap E; Gams BL; Pylipow M; Saarinen A; Gaviglio A; Thompson TR
    Pediatrics; 2013 Sep; 132(3):e587-94. PubMed ID: 23958775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. State Legislation, Regulations, and Hospital Guidelines for Newborn Screening for Critical Congenital Heart Defects - United States, 2011-2014.
    Glidewell J; Olney RS; Hinton C; Pawelski J; Sontag M; Wood T; Kucik JE; Daskalov R; Hudson J;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):625-30. PubMed ID: 26086632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Socioeconomic barriers to prenatal diagnosis of critical congenital heart disease.
    Campbell MJ; Lorch S; Rychik J; Quartermain MD; Passarella M; Groeneveld PW
    Prenat Diagn; 2021 Feb; 41(3):341-346. PubMed ID: 33169368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age.
    Chu PY; Li JS; Kosinski AS; Hornik CP; Hill KD
    J Pediatr; 2017 Feb; 181():37-41.e1. PubMed ID: 27816222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the 1-year survival rate in infants with congenital heart disease diagnosed by prenatal and postnatal ultrasound: A retrospective study.
    Han B; Tang Y; Qu X; Deng C; Wang X; Li J
    Medicine (Baltimore); 2021 Jan; 100(4):e23325. PubMed ID: 33530157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and Outcomes of Congenital Heart Disease in Very Low Birth Weight Preterm Infants: An Observational Study From the Brazilian Neonatal Network Database.
    Anderson D; Aragon DC; Gonçalves-Ferri WA; Manso PH; Leal G; Krebs VLJ; Caldas JPS; Almeida JHCL; Ribeiro MAS; Silveira RC; Duarte JLMB; Penido MG; Ferreira DMLM; Alves JMS; Sakano KMK; Santos JPF; Gimenes CB; Silva NMM; Melo FPG; Venzon PS; Meneses J; Marques PF; Rugolo LMSS; Testoni D; Carmona F
    Pediatr Crit Care Med; 2021 Jan; 22(1):e99-e108. PubMed ID: 33021513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maternal Chlamydia Infection During Pregnancy and Risk of Cyanotic Congenital Heart Defects in the Offspring.
    Dong DY; Binongo JN; Kancherla V
    Matern Child Health J; 2016 Jan; 20(1):66-76. PubMed ID: 26156829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing Strategies for Critical Congenital Heart Disease Newborn Screening.
    Tsao PC; Chiang SH; Shiau YS; Chen HY; Lin HL; Ho HC; Chen MR; Chang JK; Wang JK; Chiu SN; Jeng MJ; Hsiao KJ
    Pediatrics; 2023 Mar; 151(3):. PubMed ID: 36815269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.